Cyamemazine
SIGMA/SML0321 - ≥98% (HPLC)
Synonym: 10-
CAS Number: 3546-03-0
Empirical Formula (Hill Notation): C19H21N3S
Molecular Weight: 323.46
EC Number: 222-594-2
MDL Number: MFCD00868180
Linear Formula: C19H21N3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | light yellow to yellow-green |
| form | powder |
| InChI | 1S/C19H21N3S/c1-14(12-21( |
| InChI key | SLFGIOIONGJGRT-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CC(CN(C)C)CN1c2ccccc2Sc3c |
| solubility | DMSO: ≥5 mg/mL |
| storage temp. | 2-8°C |
| Application: | Cyamemazine has been used as an internal standard and antipsychotic drug to spike plasma samples in mass spectrometry studies. It has also been used as an analytical standard in gas chromatography-tandem mass spectroscopic (GC-MS/MS) analysis. |
| Biochem/physiol Actions: | Cyamemazine belongs to the class of phenothiazine drugs. It is known to treat severe depression, schizophrenia and bipolar disorder. |
| Biochem/physiol Actions: | Cyamemazine is a potent antagonist of 5-HT2C and 5-HT3 receptors with antipsychotic and anxiolytic properties. |
| Biochem/physiol Actions: | Cyamemazine is a potent antagonist of 5-HT2C and 5-HT3 receptors. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H410 |
| Precautionary statements | P273 - P501 |
| Hazard Codes | Xi,N |
| Risk Statements | 50 |
| Safety Statements | 61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


